President Muhammadu Buhari and Vice President, Yemi Osinbajo, will on Saturday obtain pictures of AstraZeneca/Oxford COVID-19 vaccines.
This was confirmed by Dr Faisal Shuaib, the Government Director, Nationwide Main Well being Care Growth Company, at a State Home briefing in Abuja on Thursday.
Based on Shuaib, the train will enhance the boldness of Nigerians to obtain the about 4 million doses of the vaccine, which was shipped into the nation this week.
Shuaib stated, “The following step within the vaccination programme on condition that we’ve now acquired the vaccines is a launch that might be happening on the Nationwide Hospital tomorrow (Friday). The time scheduled for that launch is 10am. The launch might be carried out by the Chairman of the Presidential Process Power on COVID-19, (Boss Mustapha).
“The plan is to vaccinate the frontline well being employees that work within the therapy centre of the Nationwide Hospital, these would be the first folks similar to we’ve communicated that frontline well being employees would be the first folks to take the vaccines.
“After that, the plan is to vaccinate Mr President, Mr Vice President and strategic leaders on Saturday. Once more, we’re hopeful that when Nigerians see leaders like Mr President and Mr Vice President take the vaccines; it’ll improve their confidence across the security of the vaccines.
“As you might be properly conscious that even earlier than the vaccines arrived Nigeria, there’s loads of hesitancy. It’s a international phenomenon. Vaccine hesitancy is comparable irrespective of the place you might be, you must present the suitable info and to these individuals who have questions, we can not dismiss their cynicism.
“It’s our duty as public well being employees to not solely provide the vaccines however do the additional work when it comes to offering the sources which can be wanted and to persuade those who these vaccines are protected.”
The NPHCDA boss additionally enjoined Nigerians who want to obtain the vaccines to register on the web site of the company.